Comparative Clinical Efficacy Of Different desensitizing Agents At Relieving Dentin Hypersensitivity : A Patient Reported Outcome Based Randomized Clinical Study.

Phase 3

Completed

Conditions: Health Condition 1: K031- Abrasion of teeth

Registration Number: CTRI/2023/07/055540

Lead Sponsor: il

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Male and female patients who agreed to participate and provide written consent for the study

Age group - 20-50 years

Participant who have at least one non-carious cervical lesion (NCCL’s) i.e. incisor, cuspid or premolar with a buccal cervical defect and clinical hypersensitivity in response of minimum 2 on a visual analogue scale (VAS).

Shallow NCCL’s- lesions that had a shallow depth (less than or equal to 0.5 mm) but their breadth and height dimensions were greater than 1.0 mm.These lesions exhibited minimal dentine exposure.

Concave NCCL’s- lesions that had a greater depth than 0.5mm. Concave NCCLs did not demonstrate well-defined internal line angle. Instead, the floor of these lesions was continously curved.

Generally healthy gum tissue surrounding the tooth (no ulceration or leukoplakia)

Exclusion Criteria

Any subject that does not fall under the inclusion criteria were excluded

Using any desensitizing agent within one month

Pharmacotherapeutic histories that may compromise the protocol - including the chronic use of anti-inflammatory, analgesic and mind-altering drugs

Pregnant or lactating

Periodontal surgery in the preceding 3 months

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the primary outcome is the success of the treatment. Success will be measured as reduction in the dentinal hypersensitivity using Visual Analogue scale (VAS) after 1,4 & 8 weeks intervalTimepoint: 2 months

Secondary Outcome Measures

Name	Time	Method
The secondary outcome will be patient satisfaction. <br/ ><br>Patients will complete pain assessment (labelled magnitude scale) treatment questionnaire at baseline & follow-up visits. <br/ ><br>Four factors will be considered : duration,intensity, tolerability & description)Timepoint: 2 months